secwatch.observer — SEC 8-K summary
======================================

Issuer:     CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)
CIK:        0001801170
Form:       8-K
Filed at:   2025-02-27T23:59:59+00:00
Accession:  0001801170-25-000049
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Clover Health FY24 adjusted EBITDA $70M, net loss improves $164M; 2025 revenue guidance $1.8-1.875B
--------------------------------------------------------------------------------

- Full year 2024 GAAP net loss from continuing ops narrowed to $46M from $210M in 2023 (improvement of $164M).
- Full year 2024 Adjusted EBITDA was $70M, reversing a $42M loss in 2023; Q4 Adj. EBITDA $7.8M vs -$16.7M.
- Insurance revenue $1.344B for 2024 (+8.8% YoY); Insurance BER improved to 81.2% from 86.5%.
- For 2025, guides insurance revenue $1.8-$1.875B (37% growth) and Adjusted EBITDA $45M-$70M.
- Average Medicare Advantage membership expected 103k-107k in 2025 (~30% growth YoY at midpoint).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1801170/000180117025000049/0001801170-25-000049-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1801170/000180117025000049/clov-20250227.htm
  HTML page:      https://secwatch.observer/filing/0001801170-25-000049

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer